News | Digital Pathology

July 16, 2019 — Computational pathology company Paige announced the publication of an article in Nature Medicine ...

Time July 16, 2019
Home
News | Remote Viewing Systems

Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to quickly send 3-D DICOM volumetric data to colleagues for one-click review. The updated version provides a U.S. Food and Drug Administration (FDA)-approved 3-D DICOM web viewer with new tools such as measurements, the ability to discuss cases with messaging, viewing of mesh file types such as STL and more.

Time July 16, 2019
Home
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting, July 14-18 in San Antonio, Texas.

Time July 16, 2019
Home
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility is part of NorthStar’s staged development and dual processing pathway approach to expanding current capacity and efficiencies in Mo-99 production.

Time July 16, 2019
Home
Technology | Oncology Information Management Systems (OIMS)

RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources. RayCare is being continually developed in collaboration with some of the leading cancer centers worldwide, according to RaySearch.

Time July 15, 2019
Home
News | Radiation Dose Management

Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)] and shallow [Hp(0.07)] measurements of both photon and beta radiation.

Time July 15, 2019
Home
Feature | Radiation Dose Management | Niki Fitousi, Ph.D., and An Dedulle

One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when the dose exceeds certain thresholds. These dose thresholds are mainly based on national Diagnostic Reference Levels (DRLs), which are defined for a standard-sized patient. An advanced dose management system offers the possibility to automatically select the group of patients by defining a patient size range in terms of weight, effective diameter or Water Equivalent Diameter (WED). As weight is not always filled in, WED, an attenuation-based metric, has become the favourite parameter to indicate patient size. But how accurately is WED calculated? Are we sure that our group of standard-sized patients does not include patients with wrong size calculation? Especially when everything happens automatically, how can we know that a high dose alert does not indicate a bigger patient for whom the size was not correctly calculated?

Time July 15, 2019
Home
Sponsored Content | Blog | Contrast Media

Contrast agents improve every kind of medical image from computed tomography (CT) to magnetic resonance imaging (MR) ...

Time July 15, 2019
Home
Technology | Contrast Media

The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance imaging (MRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD). Gadavist (gadobutrol) is now the first and only contrast agent FDA-approved for use in cardiac MR, an important diagnostic tool for patients with CAD.

Time July 15, 2019
Home
Feature | Artificial Intelligence | By Greg Freiherr

Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient. Artificial ...

Time July 15, 2019
Home
Videos | Artificial Intelligence

Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by artificial ...

Time July 12, 2019
Home
Feature | Computed Tomography (CT) | By Greg Freiherr

When providers develop their own imaging protocols, they are wasting time and money, according to Timothy Szczykutowicz ...

Time July 12, 2019
Home
Videos | Digital Pathology

Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado School ...

Time July 11, 2019
Home
Technology | Radiation Dose Management

Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of data collection. The new RaySafe 452 Survey Meter is a versatile, tool that can be used for multiple situations, reducing the number of devices technicians need to carry, learn and calibrate.

Time July 11, 2019
Home
News | Ultrasound Women's Health

Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Time July 11, 2019
Home
News | CT Angiography (CTA)

Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will present at the 14th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT), July 11-14 in Baltimore. His session is titled “Building a National Centers of Excellence in Coronary Computed Tomography Angiography (CCTA) to Support Implementation in Clinical Practice.”

Time July 11, 2019
Home
News | Focused Ultrasound Therapy

GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s Exablate Neuro compatible with the Signa Premier magnetic resonance imaging (MRI) system from GE Healthcare. The Exablate Neuro is a focused ultrasound platform for treating deep in the brain with no surgical incisions. MR imaging provides a comprehensive anatomical survey of the treatment area, patient-specific planning and real-time thermal monitoring throughout the treatment.

Time July 10, 2019
Home
News | Mammography

Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-cleared artificial intelligence (AI) program for significantly enhancing early breast cancer detection for 3-D mammography. The AI program, called ProFound AI for digital breast tomosynthesis (DBT), is a technology developed by iCAD Inc.

Time July 10, 2019
Home
Subscribe Now